Picture of Sumitomo Pharma logo

4506 — Sumitomo Pharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapValue Trap

Will Extend Period Of Reduction In Executive Remuneration As Co Continues To Face Challenging Business Situation

April 4 (Reuters) - Sumitomo Pharma Co Ltd 4506.T:

SUMITOMO PHARMA CO - WILL EXTEND PERIOD OF REDUCTION IN EXECUTIVE REMUNERATION AS CO CONTINUES TO FACE CHALLENGING BUSINESS SITUATION

SUMITOMO PHARMA CO - CEO'S BASE REMUNERATION TO BE REDUCED 30% FROM APRIL TO JUNE

Source text: ID:nTSpd7c4af

Further company coverage: 4506.T

Recent news on Sumitomo Pharma

See all news